CATALYST PHARMACEUTICALS, INC. (CPRX) › Cash & EquivalentsCATALYST PHARMACEUTICALS, INC. (CPRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2002: $100.0K2008: $11.77M2009: $7.78M2010: $5.48M2011: $6.03M2012: $1.41M2013: $2.22M2014: $9.10M2015: $28.24M2016: $13.89M2017: $57.50M2018: $16.56M2019: $89.51M2020: $130.24M2021: $171.44M2022: $298.39M2023: $137.64M2024: $517.55M2025: $709.17M$709.17M2002Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$709.17M+37.0%2024$517.55M+276.0%2023$137.64M-53.9%2022$298.39M+74.0%2021$171.44M+31.6%2020$130.24M+45.5%2019$89.51M+440.6%2018$16.56M-71.2%2017$57.50M+313.9%2016$13.89M-50.8%2015$28.24M+210.4%2014$9.10M+310.5%2013$2.22M+57.2%2012$1.41M-76.6%2011$6.03M+10.1%2010$5.48M-29.6%2009$7.78M-33.9%2008$11.77M—2002$100.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share